CYTEK BIOSCIENCES, INC.

(CTKB)
  Rapport
Temps Différé Nasdaq  -  22:00 24/06/2022
11.11 USD   +6.93%
22/06Cytek Biosciences, Inc. Réaffirme ses prévisions de bénéfices pour 2022
CI
06/06Cytek Biosciences, Inc. élit Deborah Neff, Don Hardison en tant que directeur de classe I
CI
24/05Cytek Biosciences reçoit le marquage CE pour les réactifs cFluor, le kit TBNK en Europe
MT
SynthèseCotationsGraphiquesActualitésNotationsAgendaSociétéFinancesConsensusRévisionsDérivésFonds 
SynthèseToute l'actualitéReco analystesAutres languesCommuniquésPublications officiellesActualités du secteur
Actualités dans d'autres langues sur CYTEK BIOSCIENCES, INC.
22/06Cytek Biosciences, Inc. Reaffirms Earning Guidance for 2022
22/06TRANSCRIPT : Cytek Biosciences, Inc. - Analyst/Investor Day
06/06CYTEK BIOSCIENCES, INC. : Submission of Matters to a Vote of Security Holders (form 8-K)
06/06Cytek Biosciences, Inc. Elects Deborah Neff, Don Hardison as Class I Director
02/06CYTEK BIOSCIENCES : April 2022 Investor Presentation
01/06Cytek Biosciences to Host Inaugural Analyst and Investor Day
01/06Cytek Biosciences to Host Inaugural Analyst and Investor Day
24/05Cytek Biosciences Receives CE Marking for cFluor Reagents, TBNK Kit in Europe
24/05Cytek® Biosciences Receives CE Marking for Series of cFluor® Reagents, TBNK Kit
12/05INSIDER SELL : Cytek Biosciences
12/05CYTEK BIOSCIENCES, INC. Management's Discussion and Analysis of Financial Condition an..
11/05Cytek Biosciences Posts Flat Adjusted EPS, Higher Revenue for Q1; Sees 2022 Revenue at ..
11/05Cytek Biosciences Seeks M&A
11/05TRANSCRIPT : Cytek Biosciences, Inc., Q1 2022 Earnings Call, May 11, 2022
11/05Earnings Flash (CTKB) CYTEK BIOSCIENCES Reports Q1 EPS $0.01, vs. Street Est of $0.02
11/05Earnings Flash (CTKB) CYTEK BIOSCIENCES Reports Q1 Revenue $35.1M, vs. Street Est of $3..
11/05Cytek Biosciences Reports First Quarter 2022 Financial Results
11/05Cytek Biosciences Reports First Quarter 2022 Financial Results
11/05Cytek Biosciences, Inc. Provides Revenue Guidance for the Full Year 2022
11/05Cytek Biosciences, Inc. Reports Earnings Results for the First Quarter Ended March 31, ..
28/04Cytek Biosciences to Report First Quarter Financial Results on May 11, 2022
28/04Cytek Biosciences to Report First Quarter Financial Results on May 11, 2022
28/04Cytek Biosciences Appoints Todd Garland Chief Commercial Officer
28/04Cytek Biosciences, Inc. Appoints Todd Garland as Chief Commercial Officer
17/03CYTEK BIOSCIENCES, INC. Management's Discussion and Analysis of Financial Condition an..
02/03CYTEK BIOSCIENCES, INC. : Change in Directors or Principal Officers (form 8-K)
23/02CYTEK BIOSCIENCES : Reports Fourth Quarter and Full Year 2021 Financial Results - Form 8-K
23/02Cytek Biosciences, Inc. Provides Revenue Guidance for the Fiscal Year 2022
23/02Cytek Biosciences, Inc. Reports Earnings Results for the Full Year Ended December 31, 2..
23/02Earnings Flash (CTKB) CYTEK BIOSCIENCES Reports Q4 Revenue $38.9M, vs. Street Est of $3..
23/02Cytek Biosciences Reports Fourth Quarter and Full Year 2021 Financial Results
16/02Cytek to Participate in the 42nd Annual Cowen Health Care Conference
11/02Cytek Biosciences to Report Fourth Quarter and Full Year 2021 Financial Results on Febr..
19/01Certain Common Stock of Cytek Biosciences, Inc. are subject to a Lock-Up Agreement Endi..
19/01Certain Stock Options of Cytek Biosciences, Inc. are subject to a Lock-Up Agreement End..
06/01CYTEK BIOSCIENCES, INC. : Change in Directors or Principal Officers (form 8-K)
06/01Cytek Biosciences, Inc. Appoints Vera Imper as A Class II Director
05/01Cytek® Biosciences Expands Fremont Headquarters, Tripling Its Manufacturing Capacity
05/01Cytek® Biosciences Expands Fremont Headquarters, Tripling Its Manufacturing Capacity
05/01Cytek® Biosciences Expands Fremont Headquarters, Tripling Its Manufacturing Capacity
2021CYTEK BIOSCIENCES, INC.(NASDAQGS : CTKB) added to S&P Global BMI Index
2021Cytek® Biosciences Marks Milestone Achievement with Shipment of 1000th Cell Analysis Sy..
2021Cytek? Biosciences Marks Milestone Achievement with Shipment of 1,000th Cell Analysis S..
2021CYTEK BIOSCIENCES, INC. Management's Discussion and Analysis of Financial Condition an..
2021Cytek Biosciences Reports Third Quarter 2021 Financial Results - Form 8-K
2021Earnings Flash (CTKB) CYTEK BIOSCIENCES Posts Q3 Revenue $34.4M, vs. Street Est of $33...
2021Earnings Flash (CTKB) CYTEK BIOSCIENCES Posts Q3 EPS $0.02, vs. Street Est of $0.02
2021Cytek Biosciences Reports Third Quarter 2021 Financial Results
2021Cytek Biosciences Acquires Tonbo Biosciences' Cell Analysis Unit for Undisclosed Sum
2021Cytek Biosciences Acquires Tonbo Biosciences' Cell Analysis Business
2021Cytek Biosciences, Inc. Acquires Tonbo Biosciences? Cell Analysis Business
2021Cytek Biosciences, Inc. acquired Cell Analysis Business of Tonbo Biosciences.
2021Cytek Biosciences to Report Third Quarter Financial Results on November 8, 2021
2021Cytek Biosciences to Report Third Quarter Financial Results on November 8, 2021
2021Cytek® Biosciences Introduces New 25-Color Immunoprofiling Assay
2021Cytek Biosciences, Inc. Introduces New 25-Color Immunoprofiling Assay
2021CYTEK BIOSCIENCES, INC.(NASDAQGS : CTKB) added to S&P TMI Index
2021CYTEK BIOSCIENCES : Management's Discussion and Analysis of Financial Condition and Result..
2021CYTEK BIOSCIENCES : Q2 Net Income Falls, Revenue Rises
2021CYTEK BIOSCIENCES : Earnings Flash (CTKB) CYTEK BIOSCIENCES Posts Q2 Revenue $30.4M
2021Cytek Biosciences to Present at the Morgan Stanley 19th Annual Global Healthcare Confer..
2021CYTEK BIOSCIENCES : Reports Second Quarter 2021 Financial Results
2021Cytek Biosciences, Inc. Announces Unaudited Consolidated Earnings Results for the Secon..
2021CYTEK BIOSCIENCES, INC. : Entry into a Material Definitive Agreement (form 8-K)
2021CYTEK BIOSCIENCES : Says IPO Raised $237 Million After Underwriters Exercised Option to Bu..
2021Cytek Biosciences Announces Full Exercise of Underwriters' Option to Purchase Additiona..
2021CYTEK BIOSCIENCES : Announces Closing of Its Initial Public Offering
2021CYTEK BIOSCIENCES, INC. : Amendments to Articles of Inc. or Bylaws; Change in Fiscal Year,..
2021CYTEK BIOSCIENCES : Prices IPO at $17/Share, Expects $200 Million Gross Proceeds
2021Cytek Biosciences, Inc. has completed an IPO in the amount of $247.598795 million.
2021Cytek Biosciences, Inc. has filed an IPO in the amount of $100 million.
2017Cytek Biosciences, Inc. announced that it has received $12 million in funding from from..
2016Cytek Biosciences, Inc. announced that it expects to receive $15 million in funding
2015Cytoville, Inc. announced that it has received $12.25 million in funding from Eight Roa..
2015Cytoville, Inc. announced a financing transaction
Prochain événement sur CYTEK BIOSCIENCES, INC.